JWCA
REGN icon

J.W. Cole Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

J.W. Cole Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
958
+103
+12% +$70.1K 0.01% 950
2026
Q1 		$661K Buy
+855
New +$655K 0.02% 463
2025
Q4 		– Sell
-911
Closed -$512K – 1570
2025
Q3 		$512K Sell
911
-86
-9% -$48.6K 0.01% 975
2025
Q2 		$523K Buy
997
+34
+4% +$19K 0.01% 898
2025
Q1 		$611K Buy
963
+336
+54% +$231K 0.02% 707
2024
Q4 		$447K Sell
627
-175
-22% -$147K 0.02% 636
2024
Q3 		$843K Buy
802
+83
+12% +$92.4K 0.04% 436
2024
Q2 		$756K Sell
719
-36
-5% -$34.9K 0.04% 412
2024
Q1 		$727K Sell
755
-31
-4% -$29.5K 0.04% 420
2023
Q4 		$690K Buy
786
+6
+0.8% +$4.94K 0.04% 387
2023
Q3 		$642K Sell
780
-101
-11% -$79.4K 0.05% 352
2023
Q2 		$633K Sell
881
-62
-7% -$47.8K 0.05% 365
2023
Q1 		$775K Buy
943
+237
+34% +$179K 0.06% 341
2022
Q4 		$509K Sell
706
-13
-2% -$9.59K 0.04% 414
2022
Q3 		$495K Sell
719
-60
-8% -$37.8K 0.04% 401
2022
Q2 		$460K Sell
779
-63
-7% -$41K 0.04% 430
2022
Q1 		$588K Sell
842
-12
-1% -$7.59K 0.04% 409
2021
Q4 		$539K Sell
854
-39
-4% -$24K 0.04% 438
2021
Q3 		$540K Sell
893
-2
-0.2% -$1.24K 0.04% 246
2021
Q2 		$500K Buy
895
+457
+104% +$232K 0.04% 435
2021
Q1 		$207K Sell
438
-98
-18% -$47.7K 0.02% 619
2020
Q4 		$259K Buy
536
+46
+9% +$24.8K 0.03% 516
2020
Q3 		$274K Buy
+490
New +$297K 0.02% 574

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

J.W. Cole Advisors's REGN Position: Q2 2026 in Review

J.W. Cole Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, buying an estimated $70.1K and bringing the position to 958 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #950.

J.W. Cole Advisors first reported a position in REGN in Q3 2020 and has held it in 23 quarters since. The position peaked at $843K in Q3 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • J.W. Cole Advisors held 958 shares of Regeneron Pharmaceuticals worth $597K as of Q2 2026.
  • J.W. Cole Advisors bought 103 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $70.1K.
  • Regeneron Pharmaceuticals made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #950 holding.
  • J.W. Cole Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • J.W. Cole Advisors's Regeneron Pharmaceuticals position peaked at $843K in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.